Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 27, 2026
Reporting period
Not applicable
Filed with the SEC
May 29, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001809519-26-000117
Filed / recorded
May 29, 2026, 9:58 PM UTC
Added to OQRO
Oct 7, 2026, 5:51 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
GoodRx Holdings, Inc.
Issuer CIK
1809519
Ticker
GDRX
Reporting person
Ronald E Bruehlman
Relationship
Director
Security
Class A Common Stock
Table
Non-derivative (Table I)
Transaction date
May 27, 2026
Transaction code
A
Shares / units
4,642
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
133,918
Ownership form
Direct
Amendment
No
Footnotes from the filing
Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest as to 2% of the underlying shares on May 31, 2026, and the remining 98% will vest in substantially equal monthly installments on last day of each month over the following 7 months, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
